Skip to main content
. 2017 Oct 25;7(3):388–398. doi: 10.1016/j.ijpddr.2017.10.006

Fig. 3.

Fig. 3

Ivermectin (IVM) concentration response curves in Population 1 ‘resistant’ and 2 ‘susceptible’ (Pop 1, Pop 2) in the larval development test (LDT) and larval migration inhibition test (LMIT), with and without the addition of the P-glycoprotein inhibitors ketoconazole (K), ivermectin aglycone (IVM-AG) and pluronic 85 (P85).